About
Pediatric Treatments
Areas of Focus
Categories
Drug Delivery & Formulation
Team (9)
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
414
By Phase
PHASE2/PHASE3: 2PHASE2: 1PHASE1: 1
By Status
COMPLETED: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06364072Lead Sponsor
Safety, Tolerability, Analgesic Effect, and Feasibility of Intranasal CT001 in Pediatric Patients
PHASE2/PHASE3Completed
155 participants
Started: May 27, 2024 · Completed: May 9, 2025
NCT05508594Lead Sponsor
Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001
PHASE2/PHASE3Completed
220 participants
Started: Sep 5, 2022 · Completed: Oct 5, 2023
NCT04897750Lead Sponsor
Pharmacokinetic Study of Intranasal CT001 in Children 1-17 Years of Age Undergoing Elective Surgical Procedures
PHASE2Completed
25 participants
Started: Aug 19, 2021 · Completed: May 16, 2022
NCT04807335Lead Sponsor
Study of CT001 in Healthy Volunteers
PHASE1Completed
14 participants
Started: Mar 17, 2021 · Completed: Jun 2, 2021
Locations (1)
Headquarters
Copenhagen, Denmark
Map
Loading map...